FDA won’t review Moderna application for first mRNA-based flu vaccine

  • Posted on February 10, 2026
  • By Washington Post
  • 3 Views
FDA won’t review Moderna application for first mRNA-based flu vaccine

The decision, which shocked company officials, comes as the FDA says it will take a stricter approach to federal vaccine approvals.
continue reading...

Author
Washington Post

You May Also Like